Brandon Mancini, MD
Radiation Oncology · Grand Rapids, MINPI 1366731838
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Lantheus Medical Imaging, Inc. at 42.3% of the total. 2025 is the largest year on record at $15,564, more than ten times the $18 reported in 2019. Among radiation oncology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $842.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lantheus Medical Imaging, Inc.$13K
- Progenics Pharmaceuticals, Inc.$9K
- Novartis$3K
- Astrazeneca UK Limited$3K
- Telix Pharmaceuticals$2K
- AstraZeneca$1K
- plus $172 from 3 others
Across 85 payments — averaging $15,376 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$611K
- Progenics Pharmaceuticals, Inc.$408K
- Lantheus Medical Imaging, Inc.$182K
- Telix Pharmaceuticals$105K
- E.r. Squibb & Sons, L.L.C.$1K
What the payments were for
- Consulting fees$13,45844%
- Speaking & faculty fees$12,17040%
- Travel & lodging$2,99610%
- Food & beverage$1,7186%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 12 | $12,831 |
| Progenics Pharmaceuticals, Inc. | 11 | $8,556 |
| Novartis | 3 | $2,952 |
| Astrazeneca UK Limited | 1 | $2,730 |
| Telix Pharmaceuticals | 5 | $1,964 |
| AstraZeneca | 1 | $1,138 |
| Eli Lilly | 1 | $105 |
| GE HealthCare | 1 | $49 |
| Lilly USA, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$30,342 in reported general payments places this provider in the 95th percentile of 198 radiation oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Grand Rapids
- Frank ViciniPontiac$231K
- Thomas BoikeClarkston$171K
- Farzan SiddiquiDetroit$72K
- Daniel WahlAnn Arbor$42K
- Daniel ChangAnn Arbor$38K
- Shruti JollyAnn Arbor$30K
- Alvaro MartinezFarmington Hills$24K
- James KaneAnn Arbor$19K
- M Salim SiddiquiDetroit$17K
- Parag ParikhDetroit$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.